Skip to Main Content

Paper Details

Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.
Neuro Oncol
13
2021
Cancer, DRD2, DRD2 mRNA, EGFR, Epidermal growth factor receptor, ONC201, PDX glioblastoma lines, constitutively, dopamine, dopamine receptor D2, glioblastoma, glioblastomas, growth factor receptor, haloperidol, mRNA profiles, patient, patient-derived xenograft (PDX) glioblastoma models, patients, primary brain tumor, variant (v)III
Author NameAffiliation
Frank B FurnariLudwig Institute of Cancer Research, University of California San Diego
Joshua E Allen
Clark C ChenUniversity of Minnesota
  • 1 - 3

Datasets

Release 1.2